Mizuho Securities USA LLC Decreases Stake in HCA Healthcare, Inc. (NYSE:HCA)

Key Points

• Mizuho Securities USA LLC decreased its stake in HCA Healthcare, Inc. by 17.2%, reducing its holdings to 14,317 shares valued at approximately $4.95 million.
• COO Jon M. Foster sold 15,698 shares of HCA stock, representing a 55.38% decrease in his position, with the transaction valued at about $5.8 million.
• HCA Healthcare reported $6.84 earnings per share (EPS) for the quarter, surpassing analyst estimates and indicating a 6.4% year-over-year revenue increase.

Mizuho Securities USA LLC reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 17.2% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 14,317 shares of the company's stock after selling 2,968 shares during the period. Mizuho Securities USA LLC's holdings in HCA Healthcare were worth $4,947,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in HCA. Brighton Jones LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth $1,021,000. Glass Jacobson Investment Advisors llc acquired a new position in shares of HCA Healthcare during the 4th quarter worth $143,000. Distillate Capital Partners LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth $24,160,000. Legacy Investment Solutions LLC raised its stake in HCA Healthcare by 99.0% in the 4th quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock valued at $62,000 after purchasing an additional 95 shares during the last quarter. Finally, Sagespring Wealth Partners LLC acquired a new position in HCA Healthcare in the 4th quarter valued at about $2,656,000. Institutional investors and hedge funds own 62.73% of the company's stock.

Insider Activity

In related news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the sale, the chief operating officer directly owned 12,646 shares of the company's stock, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.30% of the company's stock.

HCA Healthcare Stock Performance

Shares of HCA opened at $381.84 on Friday. The business's 50 day moving average is $369.74 and its two-hundred day moving average is $349.36. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The firm has a market cap of $89.35 billion, a price-to-earnings ratio of 16.05, a PEG ratio of 1.20 and a beta of 1.39. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. The company had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%. HCA Healthcare's quarterly revenue was up 6.4% on a year-over-year basis. During the same period in the prior year, the company posted $5.50 EPS. Analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's dividend payout ratio is currently 12.11%.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on HCA shares. Truist Financial boosted their target price on shares of HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a research note on Wednesday, July 16th. Morgan Stanley cut their target price on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a research note on Monday, July 28th. Stephens raised shares of HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Royal Bank Of Canada lowered their price target on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a report on Monday, July 28th. Finally, JPMorgan Chase & Co. lifted their price target on HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a report on Monday, August 4th. Nine investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $395.69.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.